Martina Bebin is professor of neurology and pediatrics at the University of Alabama at Birmingham. She is also co-director of the university’s Tuberous Sclerosis Clinic.
Martina Bebin
Professor
University of Alabama at Birmingham
From this contributor
Can an epilepsy drug prevent autism features?
An epilepsy drug may prevent seizures in infants with tuberous sclerosis and alleviate their autism features, says Martina Bebin.
Can an epilepsy drug prevent autism features?
By
Nicholette Zeliadt
29 August 2017 | 4 min read
Explore more from The Transmitter
What leeches reveal about movement
Lidia Szczupak turned to the animals to explore how the nervous system coordinates movement.
What leeches reveal about movement
Lidia Szczupak turned to the animals to explore how the nervous system coordinates movement.
By
Claudia López Lloreda
27 August 2026 | 6 min read
By
Keerthana Iyer, Arish Mudra Rakshasa-Loots, Ana Silva, Violetta Zujovic
27 August 2026
6 min read
Redefining underrepresentation in global neuroscience
Shifting the focus of equity initiatives from identity categories to structural barriers can reveal overlooked challenges and increase support and participation worldwide.
Redefining underrepresentation in global neuroscience
Shifting the focus of equity initiatives from identity categories to structural barriers can reveal overlooked challenges and increase support and participation worldwide.
By
Keerthana Iyer, Arish Mudra Rakshasa-Loots, Ana Silva, Violetta Zujovic
27 August 2026 | 6 min read
Scientific talent is global. Access to the world’s scientific stage is not.
Neuroscience in Chile, and across Latin America, does not lack talent or ideas, but the systems that make science visible—prestigious journals, conferences and networks—increasingly price its researchers out.
Scientific talent is global. Access to the world’s scientific stage is not.
Neuroscience in Chile, and across Latin America, does not lack talent or ideas, but the systems that make science visible—prestigious journals, conferences and networks—increasingly price its researchers out.
By
Vicente Medel
27 August 2026 | 8 min read